Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion”

252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 252 results

Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Large-scale testing (Phase 3)UnknownNCT04687163
What this trial is testing

Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 400
Early research (Phase 1)Looking for participantsNCT07021534
What this trial is testing

Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial

Who this might be right for
Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
Zhejiang University 12
Large-scale testing (Phase 3)Looking for participantsNCT06201065
What this trial is testing

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Ended earlyNCT05220722
What this trial is testing

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
TriSalus Life Sciences, Inc. 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012798
What this trial is testing

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02967887
What this trial is testing

Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC

Who this might be right for
Hepatocellular Carcinoma Non-Resectable
CbsBioscience 96
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Testing effectiveness (Phase 2)UnknownNCT05511051
What this trial is testing

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Testing effectiveness (Phase 2)UnknownNCT01412593
What this trial is testing

Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis

Who this might be right for
End Stage Liver Disease
King Saud University 50
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Testing effectiveness (Phase 2)UnknownNCT05406206
What this trial is testing

Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Who this might be right for
Advanced Colorectal CarcinomaLiver Metastasis Colon Cancer
Peking University Cancer Hospital & Institute 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Large-scale testing (Phase 3)Looking for participantsNCT06857773
What this trial is testing

Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy

Who this might be right for
Colorectal NeoplasmsFloxuridineLiver Metastases+1 more
The Netherlands Cancer Institute 306
Large-scale testing (Phase 3)UnknownNCT03468231
What this trial is testing

HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)UnknownNCT05839197
What this trial is testing

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

Who this might be right for
Macrotrabecular Massive Hepatocellular Carcinoma
Wan-Guang Zhang 38
Load More Results